Familial Prostate Cancer
Genetic Analysis of Hereditary Prostate Cancer
|3||Active, not recruiting||
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer and Their First-Degree Relatives
Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a
Epidemiologic and Genetic Study on Familial Prostate Cancer
Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer
† Study has passed its completion date and status has not been verified in more than two years.